Prudential Financial Inc Equillium, Inc. Transaction History

Prudential Financial Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.73 - $3.0 $24,966 - $102,600	-34,200 Reduced 52.29%	31,200 $72,000
Q4 2023 Feb 13, 2024	BUY	$0.48 - $0.74 $3,648 - $5,624	7,600 Added 13.15%	65,400 $47,000
Q2 2023 Aug 11, 2023	BUY	$0.49 - $0.79 $28,322 - $45,662	57,800 New	57,800 $43,000

11.3M

Ticker EQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,352,100
Market Cap $25.8M
Description
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.